Chemical characterization of substance P-like immunoreactivity in primary afferent neurones

A. Harmar,P. Keen

DOI: https://doi.org/10.1016/0006-8993(81)90227-4

IF: 3.61

1981-09-07

Brain Research

Abstract:

What problem does this paper attempt to address?

Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats

Wenjing Zhang,Yang Wang,Shuyun Dong,Rajarshi Choudhury,Yongfeng Jin,Zefeng Wang

DOI: https://doi.org/10.1038/mt.2013.251

IF: 12.91

2014-01-01

Molecular Therapy

Abstract:Myotonic dystrophy type 1 (DM1) is caused by the expansion of (CTG)n in the 3' untranslated region of the dystrophia myotonica-protein kinase (DMPK) gene, which is transcribed as (CUG)n repeats that accumulate in the nucleus. The RNA repeats specifically sequester or change the expression levels of several RNA-binding proteins, leading to aberrant splicing of many target genes. In this study, we developed artificial site-specific RNA endonucleases (ASREs) that specifically bind and cleave (CUG)n repeats RNA. We have generated one ASRE that can target the expanded RNA repeats in DM1 patient cells and specifically degrade the pathogenic DMPK messenger RNAs with minimal effect on wild-type alleles. Such ASRE treatment significantly decreased the number of nuclear foci in DM1 patient cells and can reverse the missplicing of many genes affected in DM1 patients. Taken together, the application of ASRE provides a new route of gene therapy for DM1 treatment.
Phase-separated stress granules and processing bodies are compromised in Myotonic Dystrophy Type 1

Selma Gulyurtlu,Monika S Magon,Patrick Guest,Panagiotis P Papavasiliou,Alan R Prescott,Judith E Sleeman

DOI: https://doi.org/10.1101/2021.06.14.448303

2021-06-15

Abstract:Summary RNA regulation in mammalian cells requires complex physical compartmentalisation using structures thought to be formed by liquid-liquid phase separation. Disruption of these structures is implicated in numerous degenerative diseases. Myotonic Dystrophy Type 1 (DM1) is a multi-systemic trinucleotide repeat disorder resulting from a CTG expansion in the dystonia myotonica protein kinase gene (DMPK). The cellular hall-mark of DM1 is the formation of nuclear foci containing expanded DMPK RNA (CUGexp). We report here the deregulation of stress granules and processing bodies (P-bodies), two cytoplasmic structures key for mRNA regulation, in cell culture models of DM1. Alterations to the rates of formation and dispersal of stress granules suggest an altered ability to respond to stress associated with DM1, while changes to the structure and dynamics of stress granules and P-bodies suggest that a more widespread alteration to the biophysical properties of cellular structures may be a consequence of the presence of CUGexp RNA.
MBNL splicing factors regulate the microtranscriptome of skeletal muscles

Agnieszka Piasecka,Michał W Szcześniak,Michał Sekrecki,Arkadiusz Kajdasz,Łukasz J Sznajder,Anna Baud,Krzysztof Sobczak

DOI: https://doi.org/10.1093/nar/gkae774

2024-10-28

Abstract:Muscleblind like splicing regulators (MBNLs) govern various RNA-processing steps, including alternative splicing, polyadenylation, RNA stability and mRNA intracellular localization. In myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, MBNLs are sequestered on toxic RNA containing expanded CUG repeats, which leads to disruption of MBNL-regulated processes and disease features of DM1. Herein, we show the significance of MBNLs in regulating microtranscriptome dynamics during the postnatal development of skeletal muscles and in microRNA (miRNA) misregulation observed in mouse models and patients with DM1. We identify multiple miRNAs sensitive to MBNL proteins insufficiency and reveal that many of them were postnatally regulated, which correlates with increases in the activity of these proteins during this process. In adult Mbnl1-knockout mice, miRNA expression exhibited an adult-to-newborn shift. We hypothesize that Mbnl1 deficiency influences miRNA levels through a combination of mechanisms. First, the absence of Mbnl1 protein results in alterations to the levels of pri-miRNAs. Second, MBNLs affect miRNA biogenesis by regulating the alternative splicing of miRNA primary transcripts. We propose that the expression of miR-23b, miR-27b and miR-24-1, produced from the same cluster, depends on the MBNL-sensitive inclusion of alternative exons containing miRNA sequences. Our findings suggest that MBNL sequestration in DM1 is partially responsible for altered miRNA activity. This study provides new insights into the biological roles and functions of MBNL proteins as regulators of miRNA expression in skeletal muscles.
MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination

Charles Frison-Roche,Célia Martin Demier,Steve Cottin,Jeanne Lainé,Ludovic Arandel,Marius Halliez,Mégane Lemaitre,Xavière Lornage,Laure Strochlic,Maurice S Swanson,Cécile Martinat,Julien Messéant,Denis Furling,Frédérique Rau

DOI: https://doi.org/10.1093/brain/awae336

IF: 14.5

2024-10-27

Brain

Abstract:Muscleblind-like proteins (MBNLs) are a family of RNA-binding proteins that play essential roles in the regulation of RNA metabolism. Beyond their canonical role in RNA regulation, MBNL proteins have emerged as key players in the pathogenesis of Myotonic Dystrophy type 1 (DM1). In DM1, sequestration of MBNL proteins by expansion of the CUG repeat RNA leads to functional depletion of MBNL, resulting in deregulated alternative splicing and aberrant RNA processing, which underlie the clinical features of the disease. While attention to MBNL proteins has focused on their functions in skeletal muscle, new evidence suggests that their importance extends to motor neurons (MNs), pivotal cellular components in the control of motor skills and movement. To address this question, we generated conditional double knockout mice in which Mbnl1 and Mbnl2 were specifically deleted in motor neurons (MN-dKO). Adult MN-dKO mice develop gait coordination deficits associated with structural and ultrastructural defects in the neuromuscular junction, indicating that MBNL activity in MNs is crucial for the maintenance of the neuromuscular junction. In addition, transcriptome analysis performed on the spinal cord of MN-dKO mice identified mis-splicing events in genes associated with synaptic transmission and neuromuscular junction homeostasis. In summary, our results highlight the complex roles and regulatory mechanisms of MBNL proteins in MNs for muscle function and locomotion. This work provides valuable insights into fundamental aspects of RNA biology and offers promising avenues for therapeutic intervention in DM1 as well as a range of diseases associated with RNA dysregulation.

neurosciences,clinical neurology
rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

Chantal Sellier,Estefanía Cerro-Herreros,Markus Blatter,Fernande Freyermuth,Angeline Gaucherot,Frank Ruffenach,Partha Sarkar,Jack Puymirat,Bjarne Udd,John W Day,Giovanni Meola,Guillaume Bassez,Harutoshi Fujimura,Masanori P Takahashi,Benedikt Schoser,Denis Furling,Ruben Artero,Frédéric H T Allain,Beatriz Llamusi,Nicolas Charlet-Berguerand

DOI: https://doi.org/10.1038/s41467-018-04370-x

2018-05-22

Abstract:Myotonic dystrophy type 1 and type 2 (DM1, DM2) are caused by expansions of CTG and CCTG repeats, respectively. RNAs containing expanded CUG or CCUG repeats interfere with the metabolism of other RNAs through titration of the Muscleblind-like (MBNL) RNA binding proteins. DM2 follows a more favorable clinical course than DM1, suggesting that specific modifiers may modulate DM severity. Here, we report that the rbFOX1 RNA binding protein binds to expanded CCUG RNA repeats, but not to expanded CUG RNA repeats. Interestingly, rbFOX1 competes with MBNL1 for binding to CCUG expanded repeats and overexpression of rbFOX1 partly releases MBNL1 from sequestration within CCUG RNA foci in DM2 muscle cells. Furthermore, expression of rbFOX1 corrects alternative splicing alterations and rescues muscle atrophy, climbing and flying defects caused by expression of expanded CCUG repeats in a Drosophila model of DM2.
Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Jiss M Louis,Jesus A Frias,Jacob H Schroader,Lindsey A Jones,Emily E Davey,Claudia D Lennon,Jacob Chacko,John D Cleary,J Andrew Berglund,Kaalak Reddy

DOI: https://doi.org/10.1093/hmg/ddae125

2024-08-24

Abstract:Myotonic dystrophy type 1 (DM1) is a heterogeneous multisystemic disease caused by a CTG repeat expansion in DMPK. Transcription of the expanded allele produces toxic CUG repeat RNA that sequesters the MBNL family of alternative splicing (AS) regulators into ribonuclear foci, leading to pathogenic mis-splicing. To identify genetic modifiers of toxic CUG RNA levels and the spliceopathy, we performed a genome-scale siRNA screen using an established HeLa DM1 repeat-selective screening platform. We unexpectedly identified core spliceosomal proteins as a new class of modifiers that rescue the spliceopathy in DM1. Modest knockdown of one of our top hits, SNRPD2, in DM1 fibroblasts and myoblasts, significantly reduces DMPK expression and partially rescues MBNL-regulated AS dysfunction. While the focus on the DM1 spliceopathy has centered around the MBNL proteins, our work reveals an unappreciated role for MBNL:spliceosomal protein stoichiometry in modulating the spliceopathy, revealing new biological and therapeutic avenues for DM1.
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model

Alicia J Angelbello,Suzanne G Rzuczek,Kendra K Mckee,Jonathan L Chen,Hailey Olafson,Michael D Cameron,Walter N Moss,Eric T Wang,Matthew D Disney

DOI: https://doi.org/10.1073/pnas.1901484116

2019-04-16

Abstract:Myotonic dystrophy type 1 (DM1) is an incurable neuromuscular disorder caused by an expanded CTG repeat that is transcribed into r(CUG)exp The RNA repeat expansion sequesters regulatory proteins such as Muscleblind-like protein 1 (MBNL1), which causes pre-mRNA splicing defects. The disease-causing r(CUG)exp has been targeted by antisense oligonucleotides, CRISPR-based approaches, and RNA-targeting small molecules. Herein, we describe a designer small molecule, Cugamycin, that recognizes the structure of r(CUG)exp and cleaves it in both DM1 patient-derived myotubes and a DM1 mouse model, leaving short repeats of r(CUG) untouched. In contrast, oligonucleotides that recognize r(CUG) sequence rather than structure cleave both long and short r(CUG)-containing transcripts. Transcriptomic, histological, and phenotypic studies demonstrate that Cugamycin broadly and specifically relieves DM1-associated defects in vivo without detectable off-targets. Thus, small molecules that bind and cleave RNA have utility as lead chemical probes and medicines and can selectively target disease-causing RNA structures to broadly improve defects in preclinical animal models.
Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration

Ramesh S. Yadava,Mahua Mandal,Mani S. Mahadevan

DOI: https://doi.org/10.3390/ijms25052687

IF: 5.6

2024-02-27

International Journal of Molecular Sciences

Abstract:Loss of function of members of the muscleblind-like (MBNL) family of RNA binding proteins has been shown to play a key role in the spliceopathy of RNA toxicity in myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults and children. MBNL1 and MBNL2 are the most abundantly expressed members in skeletal muscle. A key aspect of DM1 is poor muscle regeneration and repair, leading to dystrophy. We used a BaCl2-induced damage model of muscle injury to study regeneration and effects on skeletal muscle satellite cells (MuSCs) in Mbnl1∆E3/∆E3 and Mbnl2∆E2/∆E2 knockout mice. Similar experiments have previously shown deleterious effects on these parameters in mouse models of RNA toxicity. Muscle regeneration in Mbnl1 and Mbnl2 knockout mice progressed normally with no obvious deleterious effects on MuSC numbers or increased expression of markers of fibrosis. Skeletal muscles in Mbnl1∆E3/∆E3/ Mbnl2∆E2/+ mice showed increased histopathology but no deleterious reductions in MuSC numbers and only a slight increase in collagen deposition. These results suggest that factors beyond the loss of MBNL1/MBNL2 and the associated spliceopathy are likely to play a key role in the defects in skeletal muscle regeneration and deleterious effects on MuSCs that are seen in mouse models of RNA toxicity due to expanded CUG repeats.

biochemistry & molecular biology,chemistry, multidisciplinary
Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

Selma Gulyurtlu,Monika S. Magon,Patrick Guest,Panagiotis P. Papavasiliou,Kim D. Morrison,Alan R. Prescott,Judith E Sleeman,Judith E. Sleeman

DOI: https://doi.org/10.1242/dmm.049294

2022-07-01

Disease Models & Mechanisms

Abstract:ABSTRACT RNA regulation in mammalian cells requires complex physical compartmentalisation, using structures thought to be formed by liquid-liquid phase separation. Disruption of these structures is implicated in numerous degenerative diseases. Myotonic dystrophy type 1 (DM1) is a multi-systemic trinucleotide repeat disorder resulting from an expansion of nucleotides CTG (CTGexp) in the DNA encoding DM1 protein kinase (DMPK). The cellular hallmark of DM1 is the formation of nuclear foci that contain expanded DMPK RNA (CUGexp) (with thymine instead of uracil). We report here the deregulation of stress granules (SGs) and processing bodies (P-bodies), two cytoplasmic structures key for mRNA regulation, in cell culture models of DM1. Alterations to the rates of formation and dispersal of SGs suggest an altered ability of cells to respond to stress associated with DM1, while changes to the structure and dynamics of SGs and P-bodies suggest that a widespread alteration to the biophysical properties of cellular structures is a consequence of the presence of CUGexp RNA.

pathology,cell biology
Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy

Ashish N. Rao,Hannah M. Campbell,Xiangnan Guan,Tarah A. Word,Xander H.T. Wehrens,Zheng Xia,Thomas A. Cooper

DOI: https://doi.org/10.1172/jci.insight.143465

IF: 9.4958

2021-03-08

JCI Insight

Abstract:Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the DMPK gene. Expression of pathogenic expanded CUG repeat (CUGexp) RNA causes multisystemic disease by perturbing the functions of RNA-binding proteins, resulting in expression of fetal protein isoforms in adult tissues. Cardiac involvement affects 50% of individuals with DM1 and causes 25% of disease-related deaths. We developed a transgenic mouse model for tetracycline-inducible and heart-specific expression of human DMPK mRNA containing 960 CUG repeats. CUGexp RNA is expressed in atria and ventricles and induced mice exhibit electrophysiological and molecular features of DM1 disease, including cardiac conduction delays, supraventricular arrhythmias, nuclear RNA foci with Muscleblind protein colocalization, and alternative splicing defects. Importantly, these phenotypes were rescued upon loss of CUGexp RNA expression. Transcriptome analysis revealed gene expression and alternative splicing changes in ion transport genes that are associated with inherited cardiac conduction diseases, including a subset of genes involved in calcium handling. Consistent with RNA-Seq results, calcium-handling defects were identified in atrial cardiomyocytes isolated from mice expressing CUGexp RNA. These results identify potential tissue-specific mechanisms contributing to cardiac pathogenesis in DM1 and demonstrate the utility of reversible phenotypes in our model to facilitate development of targeted therapeutic approaches.

medicine, research & experimental
Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1

Ginny R Morriss,Kimal Rajapakshe,Shixia Huang,Cristian Coarfa,Thomas A Cooper

DOI: https://doi.org/10.1093/hmg/ddy192

IF: 5.1214

2018-05-16

Human Molecular Genetics

Abstract:Myotonic dystrophy type 1 (DM1) is a multi-systemic disease resulting in severe muscle weakening and wasting. DM1 is caused by expansion of CTG repeats in the 3' untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. We have developed an inducible, skeletal muscle-specific mouse model of DM1 (CUG960) that expresses 960 CUG repeat-expressing animals (CUG960) in the context of human DMPK exons 11-15. CUG960 RNA-expressing mice induced at postnatal day 1, as well as adult-onset animals, show clear, measurable muscle wasting accompanied by severe histological defects including central myonuclei, reduced fiber cross-sectional area, increased percentage of oxidative myofibers, the presence of nuclear RNA foci that colocalize with Mbnl1 protein, and increased Celf1 protein in severely affected muscles. Importantly, muscle loss, histological abnormalities and RNA foci are reversible, demonstrating recovery upon removal of toxic RNA. RNA-seq and protein array analysis indicate that the balance between anabolic and catabolic pathways that normally regulate muscle mass may be disrupted by deregulation of platelet derived growth factor receptor β signaling and the PI3K/AKT pathways, along with prolonged activation of AMP-activated protein kinase α signaling. Similar changes were detected in DM1 skeletal muscle compared with unaffected controls. The mouse model presented in this paper shows progressive skeletal muscle wasting and has been used to identify potential molecular mechanisms underlying skeletal muscle loss. The reversibility of the phenotype establishes a baseline response for testing therapeutic approaches.

genetics & heredity,biochemistry & molecular biology
Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy

Kuang-Yung Lee,Carol Seah,Ching Li,Yu-Fu Chen,Chwen-Yu Chen,Ching-I Wu,Po-Cheng Liao,Yu-Chiau Shyu,Hailey R Olafson,Kendra K McKee,Eric T Wang,Chi-Hsiao Yeh,Chao-Hung Wang

DOI: https://doi.org/10.1093/hmg/ddac108

IF: 5.1214

2022-05-14

Human Molecular Genetics

Abstract:Abstract Myotonic dystrophy (DM) is caused by expansions of C(C)TG repeats in the non-coding regions of the DMPK and CNBP genes, and DM patients often suffer from sudden cardiac death due to lethal conduction block or arrhythmia. Specific molecular changes that underlie DM cardiac pathology have been linked to repeat-associated depletion of Muscleblind-like (MBNL) 1 and 2 proteins and upregulation of CUGBP, Elav-like family member 1 (CELF1). Hypothesis solely targeting MBNL1 or CELF1 pathways that could address all the consequences of repeat expansion in heart remained inconclusive, particularly when the direct cause of mortality and results of transcriptome analyses remained undetermined in Mbnl compound knockout (KO) mice with cardiac phenotypes. Here, we develop Myh6-Cre double KO (DKO) (Mbnl1−/−; Mbnl2cond/cond; Myh6-Cre+/−) mice to eliminate Mbnl1/2 in cardiomyocytes and observe spontaneous lethal cardiac events under no anesthesia. RNA sequencing recapitulates DM heart spliceopathy and shows gene expression changes that were previously undescribed in DM heart studies. Notably, immunoblotting reveals a nearly 6-fold increase of Calsequestrin 1 and 50% reduction of epidermal growth factor proteins. Our findings demonstrate that complete ablation of MBNL1/2 in cardiomyocytes is essential for generating sudden death due to lethal cardiac rhythms and reveal potential mechanisms for DM heart pathogenesis.

genetics & heredity,biochemistry & molecular biology
Biological effects of low level exposures to ionizing radiation: Theory and practice

Shu-zheng Liu

DOI: https://doi.org/10.1177/0960327109363967

2010-03-23

Abstract:This paper briefly reviewed recent reports on the epidemiological and experimental data on low dose radiation effects that support the concept of radiation hormesis. These reports point to the possibility of existence of a threshold dose in cancer induction by ionizing radiation and in some cases the occurrence of hormetic effects with stimulation of host defense mechanisms. The possibility of the use of low dose radiation in cancer treatment to improve the outcome of conventional radiotherapy was raised by citing previous reports on experimental studies, which showed increased efficacy in tumor control with significant reduction of total dose of radiation when low dose radiation was used in the combined treatment protocol.
Aberrant Myokine Signaling in Congenital Myotonic Dystrophy

Masayuki Nakamori,Kohei Hamanaka,James D. Thomas,Eric T. Wang,Yukiko K. Hayashi,Masanori P. Takahashi,Maurice S. Swanson,Ichizo Nishino,Hideki Mochizuki

DOI: https://doi.org/10.1016/j.celrep.2017.10.018

IF: 8.8

2017-10-01

Cell Reports

Abstract:Myotonic dystrophy types 1 (DM1) and 2 (DM2) are dominantly inherited neuromuscular disorders caused by a toxic gain of function of expanded CUG and CCUG repeats, respectively. Although both disorders are clinically similar, congenital myotonic dystrophy (CDM), a severe DM form, is found only in DM1. CDM is also characterized by muscle fiber immaturity not observed in adult DM, suggesting specific pathological mechanisms. Here, we revealed upregulation of the interleukin-6 (IL-6) myokine signaling pathway in CDM muscles. We also found a correlation between muscle immaturity and not only IL-6 expression but also expanded CTG repeat length and CpG methylation status upstream of the repeats. Aberrant CpG methylation was associated with transcriptional dysregulation at the repeat locus, increasing the toxic RNA burden that upregulates IL-6. Because the IL-6 pathway is involved in myocyte maturation and muscle atrophy, our results indicate that enhanced RNA toxicity contributes to severe CDM phenotypes through aberrant IL-6 signaling.

cell biology
Bulimia: some psychological considerations.

L. Whitaker

DOI: https://doi.org/10.1080/07448481.1986.9938978

1986-11-01

Journal of American College Health

Abstract:
RNA mis-splicing in children with myotonic dystrophy is associated with physical function

Julia M Hartman,Kobe Ikegami,Marina Provenzano,Kameron Bates,Amanda Butler,Aileen S Jones,Kiera N Berggren,Jeanne Dekdebrun,Marnee J McKay,Jennifer N Baldwin,Kayla M.D. Cornett,Joshua Burns,Michael Kiefer,Nicholas E Johnson,Melissa A Hale,DMCRN

DOI: https://doi.org/10.1101/2024.07.03.600889

2024-07-03

Abstract:Objectives: Dysregulated RNA alternative splicing is the hallmark of myotonic dystrophy type 1 (DM1). However, the association between RNA mis-splicing and physical function in children with the most severe form of disease, congenital myotonic dystrophy (CDM), is unknown. Methods: 82 participants (42 DM1 adults & 40 CDM children) with muscle biopsies and measures of myotonia, motor function, and strength were combined from five observational studies. Data were normalized and correlated with an aggregate measure of alternative splicing dysregulation, [MBNL] in skeletal muscle biopsies. Multiple linear regression analysis was performed to predict [MBNL] using clinical outcome measures alone. Similar analyses were performed to predict 12-month physical function using baseline metrics. Results: Myotonia (measured via vHOT) was significantly correlated with RNA mis-splicing in our cross-sectional population of all DM1 individuals; CDM participants alone displayed no myotonia despite a similar range of RNA mis-splicing. Measures of motor performance and muscle strength were significantly associated with [MBNL] in our cohort of all DM1 individuals and when assessing CDM children independently. Multiple linear regression analyses yielded two models capable of predicting [MBNL]inferred from select clinical outcome assessments alone in all subjects (adjusted R = 0.6723) or exclusively in CDM children (adjusted R = 0.5875). Interpretation: Our findings establish significant correlations between skeletal muscle performance and a composite measure of alternative splicing dysregulation, [MBNL] , in DM1. The strength of these correlations and the development of the predictive models will assist in designing efficacious clinical trials for individuals with DM1, particularly CDM.

Genetics
GGC Repeat Expansion in NOTCH2NLC Induces Dysfunction in Ribosome Biogenesis and Translation.

Yu Fan,Meng-jie Li,Jing Yang,Shuang-jie Li,Xiao-yan Hao,Jia-di Li,Yun-chao Wang,Mi-bo Tang,Chan Zhang,Jing-jing Shi,Dong-rui Ma,Meng-nan Guo,Fen Liu,Si Shen,Da-bao Yao,Chun-yan Zuo,Cheng-yuan Mao,Zheng-wei Hu,Shuo Zhang,Zhi-hua Yang,Guang-yu Guo,Jing-hua Yang,Zong-ping Xia,Yu-ming Xu,Chang-he Shi

DOI: https://doi.org/10.1093/brain/awad058

IF: 14.5

2023-01-01

Brain

Abstract:GGC repeat expansion in the 5' untranslated region (UTR) of NOTCH2NLC is associated with a broad spectrum of neurological disorders, especially neuronal intranuclear inclusion disease (NIID). Studies have found that GGC repeat expansion in NOTCH2NLC induces the formation of polyglycine (polyG)-containing protein, which is involved in the formation of neuronal intranuclear inclusions. However, the mechanism of neurotoxicity induced by NOTCH2NLC GGC repeats is unclear. Here, we used NIID patient-specific induced pluripotent stem cell (iPSC)-derived 3D cerebral organoids (3DCOs) and cellular models to investigate the pathophysiological mechanisms of NOTCH2NLC GGC repeat expansion. IPSC-derived 3DCOs and cellular models showed the deposition of polyG-containing intranuclear inclusions. The NOTCH2NLC GGC repeats could induce the upregulation of autophagic flux, enhance integrated stress response and activate EIF2α phosphorylation. Bulk RNA sequencing for iPSC-derived neurons and single-cell RNA sequencing (scRNA-seq) for iPSC-derived 3DCOs revealed that NOTCH2NLC GGC repeats may be associated with dysfunctions in ribosome biogenesis and translation. Moreover, NOTCH2NLC GGC repeats could induce the NPM1 nucleoplasm translocation, increase nucleolar stress, impair ribosome biogenesis and induce ribosomal RNA sequestration, suggesting dysfunction of membraneless organelles in the NIID cellular model. Dysfunctions in ribosome biogenesis and phosphorylated EIF2α and the resulting increase in the formation of G3BP1-positive stress granules may together lead to whole-cell translational inhibition, which may eventually cause cell death. Interestingly, scRNA-seq revealed that NOTCH2NLC GGC repeats may be associated with a significantly decreased proportion of immature neurons while 3DCOs were developing. Together, our results underscore the value of patient-specific iPSC-derived 3DCOs in investigating the mechanisms of polyG diseases, especially those caused by repeats in human-specific genes.
Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy

Stacey D. Wagner,Adam J. Struck,Riti Gupta,Dylan R. Farnsworth,Amy E. Mahady,Katy Eichinger,Charles A. Thornton,Eric T. Wang,J. Andrew Berglund

DOI: https://doi.org/10.1371/journal.pgen.1006316

IF: 4.5

2016-09-28

PLoS Genetics

Abstract:Alternative splicing is a regulated process that results in expression of specific mRNA and protein isoforms. Alternative splicing factors determine the relative abundance of each isoform. Here we focus on MBNL1, a splicing factor misregulated in the disease myotonic dystrophy. By altering the concentration of MBNL1 in cells across a broad dynamic range, we show that different splicing events require different amounts of MBNL1 for half-maximal response, and respond more or less steeply to MBNL1. Motifs around MBNL1 exon 5 were studied to assess how cis-elements mediate the MBNL1 dose-dependent splicing response. A framework was developed to estimate MBNL concentration using splicing responses alone, validated in the cell-based model, and applied to myotonic dystrophy patient muscle. Using this framework, we evaluated the ability of individual and combinations of splicing events to predict functional MBNL concentration in human biopsies, as well as their performance as biomarkers to assay mild, moderate, and severe cases of DM.

genetics & heredity
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

Jie Liu,Zhen-Ni Guo,Xiu-Li Yan,Yi Yang,Shuo Huang

DOI: https://doi.org/10.3389/fnagi.2021.755392

IF: 4.8

2021-11-15

Frontiers in Aging Neuroscience

Abstract:Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy that affects multiple systems including the muscle and heart. The mutant CTG expansion at the 3′-UTR of the DMPK gene causes the expression of toxic RNA that aggregate as nuclear foci. The foci then interfere with RNA-binding proteins, affecting hundreds of mis-spliced effector genes, leading to aberrant alternative splicing and loss of effector gene product functions, ultimately resulting in systemic disorders. In recent years, increasing clinical, imaging, and pathological evidence have indicated that DM1, though to a lesser extent, could also be recognized as true brain diseases, with more and more researchers dedicating to develop novel therapeutic tools dealing with it. In this review, we summarize the current advances in the pathogenesis and pathology of central nervous system (CNS) deficits in DM1, intervention measures currently being investigated are also highlighted, aiming to promote novel and cutting-edge therapeutic investigations.

neurosciences,geriatrics & gerontology,gerontology
Synthesis of an agarose-gelatin conjugate for use as a tissue engineering scaffold.

S. Sakai,I. Hashimoto,K. Kawakami

DOI: https://doi.org/10.1263/JBB.103.22

IF: 3.185

Journal of Bioscience and Bioengineering

Abstract:We synthesized a conjugate in which gelatin was covalently crosslinked to agarose using 1,1-carbonyldiimidazole (CDI) in dimethyl sulfoxide in order to obtain gels with cellular adhesiveness that showed a sol-to-gel transition, but no gel-to-sol transition, around body temperature. The gelatin content of the conjugate increased by 2.7-fold when the concentration of CDI was increased from 1.3 to 32.7 mM. Aqueous solutions of the conjugate gelled upon cooling from 40 degrees C to 20 degrees C, but did not remelt at 37 degrees C. The percentage of adhered cells after 4 h of culture on a gel created from a conjugate containing about 25 wt% gelatin was similar to that for cells grown on tissue culture dishes. The adhered cells proliferated on the conjugate gel during culture for a further 5 d. In addition, the conjugate used in this study did not result in mechanical instability of the resultant gel compared to that of an unmodified agarose gel. These results demonstrate that this agarose-gelatin conjugate is a good candidate material for tissue engineering.

Chemical characterization of substance P-like immunoreactivity in primary afferent neurones

Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG)n Repeats

Phase-separated stress granules and processing bodies are compromised in Myotonic Dystrophy Type 1

MBNL splicing factors regulate the microtranscriptome of skeletal muscles

MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1

Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model

Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration

Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

Reversible cardiac disease features in an inducible CUG repeat RNA–expressing mouse model of myotonic dystrophy

Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1

Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy

Biological effects of low level exposures to ionizing radiation: Theory and practice

Aberrant Myokine Signaling in Congenital Myotonic Dystrophy

Bulimia: some psychological considerations.

RNA mis-splicing in children with myotonic dystrophy is associated with physical function

GGC Repeat Expansion in NOTCH2NLC Induces Dysfunction in Ribosome Biogenesis and Translation.

Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

Synthesis of an agarose-gelatin conjugate for use as a tissue engineering scaffold.